EP Wealth Advisors LLC Acquires 21,221 Shares of Medtronic PLC $MDT

EP Wealth Advisors LLC raised its holdings in Medtronic PLC (NYSE:MDT - Free Report) by 163.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,165 shares of the medical technology company's stock after purchasing an additional 21,221 shares during the quarter. EP Wealth Advisors LLC's holdings in Medtronic were worth $3,070,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

• MarketBeat Week in Review – 08/18 - 08/22

A number of other institutional investors have also recently bought and sold shares of the business. Brighton Jones LLC lifted its holdings in Medtronic by 1,368.0% during the 4th quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company's stock worth $3,194,000 after purchasing an additional 37,265 shares in the last quarter. Bridgefront Capital LLC purchased a new position in shares of Medtronic during the 4th quarter valued at about $277,000. CoreCap Advisors LLC raised its holdings in shares of Medtronic by 16.8% during the 4th quarter. CoreCap Advisors LLC now owns 2,244 shares of the medical technology company's stock valued at $179,000 after buying an additional 322 shares in the last quarter. Diligent Investors LLC raised its holdings in shares of Medtronic by 3.2% during the 4th quarter. Diligent Investors LLC now owns 9,616 shares of the medical technology company's stock valued at $768,000 after buying an additional 300 shares in the last quarter. Finally, Deutsche Bank AG increased its stake in Medtronic by 2.1% in the 4th quarter. Deutsche Bank AG now owns 18,443,640 shares of the medical technology company's stock worth $1,473,278,000 after purchasing an additional 372,168 shares during the period. Institutional investors own 82.06% of the company's stock.

Medtronic Price Performance

Shares of MDT stock opened at $92.20 on Thursday. The stock has a market cap of $118.26 billion, a price-to-earnings ratio of 25.40, a PEG ratio of 2.36 and a beta of 0.77. The business's fifty day moving average is $90.71 and its 200 day moving average is $88.09. Medtronic PLC has a twelve month low of $79.29 and a twelve month high of $96.25. The company has a quick ratio of 1.42, a current ratio of 2.01 and a debt-to-equity ratio of 0.54.

• Medtronic: The Opportunity Gets Healthier for Income Investors

Medtronic (NYSE:MDT - Get Free Report) last issued its quarterly earnings results on Tuesday, August 19th. The medical technology company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.23 by $0.03. Medtronic had a return on equity of 14.61% and a net margin of 13.63%.The company had revenue of $8.58 billion for the quarter, compared to analysts' expectations of $8.37 billion. During the same period in the prior year, the firm earned $1.23 earnings per share. The firm's revenue for the quarter was up 7.7% on a year-over-year basis. Medtronic has set its FY 2026 guidance at 5.600-5.660 EPS. Research analysts expect that Medtronic PLC will post 5.46 EPS for the current fiscal year.

Medtronic Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 17th. Stockholders of record on Friday, September 26th will be issued a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 3.1%. The ex-dividend date of this dividend is Friday, September 26th. Medtronic's dividend payout ratio is presently 78.24%.

Wall Street Analyst Weigh In

• 5 Robotics Stocks to Buy for the Future of Automation

A number of brokerages have commented on MDT. UBS Group lifted their price target on Medtronic from $94.00 to $95.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 20th. William Blair raised Medtronic to a "hold" rating in a research note on Friday, July 11th. Mizuho lifted their price target on Medtronic from $98.00 to $100.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 16th. BTIG Research reaffirmed a "neutral" rating on shares of Medtronic in a research note on Friday, July 11th. Finally, Citigroup boosted their target price on Medtronic from $99.00 to $101.00 and gave the company a "buy" rating in a research note on Thursday, August 21st. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat.com, Medtronic currently has a consensus rating of "Moderate Buy" and a consensus price target of $102.14.

View Our Latest Research Report on Medtronic

Insider Activity

In other Medtronic news, Director William R. Jellison purchased 2,500 shares of the stock in a transaction dated Monday, August 25th. The shares were purchased at an average cost of $92.37 per share, with a total value of $230,925.00. Following the completion of the acquisition, the director directly owned 5,000 shares in the company, valued at $461,850. This trade represents a 100.00% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.26% of the stock is currently owned by insiders.

Medtronic Company Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

Read More

• Five stocks we like better than Medtronic
• 3 Natural Gas Stocks That Offer Great Dividend Yields
• Back-to-School Shopping Hits $40B: 3 Retail Stocks to Watch Now
• P/E Ratio Calculation: How to Assess Stocks
• Alphabet Stock Surges After Dodging Harsh Antitrust Remedies
• The Top 3 Healthcare Dividend Stocks to Buy and Hold
• Why Qualcomm Is Outperforming NVIDIA After Months of Lagging

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Medtronic Right Now?

Before you consider Medtronic, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medtronic wasn't on the list.

While Medtronic currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here